Byrne Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Byrne Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Hold	421	–	–	0.11%	142
2026 Q1	$207K	Sell	421 -61	-13%	-$33.1K	0.12%	131
2025 Q4	$279K	Hold	482	–	–	0.15%	107
2025 Q3	$234K	Buy	+482	New	+$224K	0.14%	108
2025 Q2	–	Sell	-613	Closed	-$256K	–	115
2025 Q1	$305K	Sell	613 -30	-5%	-$16.2K	0.23%	86
2024 Q4	$335K	Sell	643 -20	-3%	-$11K	0.24%	79
2024 Q3	$410K	Buy	+663	New	+$392K	0.28%	77
2024 Q2	–	Sell	-728	Closed	-$417K	–	82
2024 Q1	$423K	Sell	728 -25	-3%	-$14K	0.29%	79
2023 Q4	$400K	Sell	753 -65	-8%	-$31.5K	0.3%	79
2023 Q3	$414K	Sell	818 -65	-7%	-$34.6K	0.34%	72
2023 Q2	$461K	Sell	883 -2	-0.2%	-$1.08K	0.3%	95
2023 Q1	$510K	Sell	885 -72	-8%	-$40.6K	0.36%	85
2022 Q4	$527K	Sell	957 -149	-13%	-$79K	0.38%	83
2022 Q3	$561K	Sell	1,106 -4	-0.4%	-$2.24K	0.43%	79
2022 Q2	$603K	Sell	1,110 -282	-20%	-$155K	0.45%	66
2022 Q1	$822K	Buy	1,392 +255	+22%	+$146K	0.51%	63
2021 Q4	$759K	Buy	+1,137	New	+$710K	0.49%	61

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Byrne Asset Management's TMO Position: Q2 2026 in Review

Byrne Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 421 shares worth $211K. The position accounts for 0.11% of the portfolio, ranked #142.

Byrne Asset Management first reported a position in TMO in Q4 2021 and has held it in 17 quarters since. The position peaked at $822K in Q1 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Byrne Asset Management held 421 shares of Thermo Fisher Scientific worth $211K as of Q2 2026.
Byrne Asset Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.11% of Byrne Asset Management's portfolio in Q2 2026, its #142 holding.
Byrne Asset Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 17 quarters since.
Byrne Asset Management's Thermo Fisher Scientific position peaked at $822K in Q1 2022.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.